Thermopylae Holdings Ltd. - 11 Nov 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: 10%+ Owner
Signature: /s/ Carl Hansen, Director, on behalf of Thermopylae Holdings Ltd
Issuer symbol: ABCL
Transactions as of: 11 Nov 2021
Net transactions value: +$2,995,913
Form type: 4
Filing time: 15 Nov 2021, 05:05:11 UTC
Previous filing: 10 Jun 2021
Next filing: 03 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Purchase	$2,995,913	+202,960	+0.37%	$14.76	55,807,290	11 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $15.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $15.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.